[1] Oncolytic Adenovirus Armoring with and Shows Potent Antitumor Activity and Boosts CAR-T Therapy for Prostate Cancer.

[2] IL15 by continuous intravenous infusion to adult patients with solid tumors in a phase I trial induced dramatic NK-cell subset expansion